Authors
Latest:
“Be Part of the Revolution”: APPs as Primary Investigators in OncologyNurse practitioners and physician assistants can advocate to play a number of roles in oncology research, including primary investigators.
Latest:
Real-World Use of Ide-cel Provides Favorable Outcomes in CNS MyelomaPatients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma.
Latest:
Darolutamide-ADT Combination Lengthens rPFS in mHSPC Regardless of Disease VolumePatients with metastatic hormone-sensitive prostate cancer experienced increase rPFS and other efficacy end points with darolutamide plus ADT.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
How CDK4/6 Inhibitors Enable More Personalized Treatment in HR+ mBCThe amount of CDK4/6-targeting treatment options available for patients with HR-positive breast cancer allows providers to personalize treatment.
Latest:
Clinical Trials Can Open Doors for Patients With Myeloproliferative NeoplasmsClinical trials can provide patients with myeloproliferative neoplasms expanded treatment options.
Latest:
Navigating Difficult Conversations in Cancer Pain ManagementDifficult conversations in cancer pain management should include core values and principles, setting realistic expectations, and building the patient-client relationship from the very beginning.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician InsightsExperts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.
Latest:
Consistent Monitoring for ESR1 Mutations Essential in HR+, HER2- mBCPatients with HR-positive, HER2-negative metastatic breast cancer should be consistently tested for ESR1 mutations to inform next lines of therapy.
Latest:
Addressing Production and Logistic Challenges in Cell Therapy“We've had to develop a unique process and a unique cryo buffer that allows us to freeze natural killer cells and recover greater than 90% of those cells. So, the new GDA-201 cryo-preserved is now going to be an off-the-shelf product and we're going to reinstitute a multicenter study in lymphoma to include both histologies of follicular lymphoma and diffuse large B cell lymphoma.”
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
The Transformative Power of Self-Compassion, Gratitude, and Kindness in CancerThe 3 fundamental coping mechanisms patients should have embedded into their care plan are self-compassion, gratitude, and kindness.
Latest:
Creating Safe Spaces for LGBTQIA+ Patients With CancerOncology nurses and APPs can help reduce discrimination faced by patients with cancer who are members of the LGBTQIA+ community.
Latest:
Intro to AYA Patients, Survivors, and Substance UseAdolescent and young adult survivors of cancer face increased substance use risks due to developmental delays, limited support, and coping mechanisms, necessitating targeted prevention.
Latest:
Nurses Can Lead Conversations on Fertility PreservationAs prognoses continue to improve, concerns about treatment-associated fertility risks are becoming more prevalent and are often a topic of discussion between patients and their nurses or nurse practitioners.
Latest:
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and StagingExperts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Latest:
Nurse Takeaways: Latest Pembrolizumab Indication in Endometrial CancerCourtney Arn, APRN-CNP, a nurse practitioner comments on the recent approval of pembrolizumab for patients with MSI-H/dMMR advanced endometrial carcinoma.
